Ispire Files IPO to Raise $42m

Market

Feb.01.2023

Ellesmere Zhu

Ispire Technology Inc., an e-cigarette company in the US, plans to raise approximately $42 million in its upcoming initial public offering (IPO) this Tuesday (January 31st).

The company plans to issue 6 million shares at a price range of $6-$8 each, to be traded on the NASDAQ with the stock symbol ISPR. Based on 56 million outstanding shares, the company's market value will reach $392 million.

Tiger Securities Inc., TFI Securities, and SPDB International are underwriting the IPO, which is taking place amid a slowdown in new stock issuances.

Ispire reported full-year revenue of $68.1 million in its 2022 annual report, an increase from $61.3 million the previous year. The company had a net loss of $2.95 million in the six months ending December 31st 2022, with revenue of $58.8 million, compared to a net profit of $1.28 million and revenue of $47.2 million in the same period the previous year.

Ispire currently sells CBD vape devices in the US. The company is planning to develop manufacturing operations in Vietnam and California, with construction expected to begin in mid-2023 and the factory primarily involved in component assembly.

#North America #United States #Open system e-cigarettes #Market #Ispire Technologies Inc.

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.

BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift

BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift

British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents

A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.

Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices

Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices

The Maine Legislature has passed LD 1519, a bill that would establish a producer-funded stewardship program for electronic smoking devices, requiring manufacturers and importers to manage the collection, transportation, recycling and disposal of end-of-life products, particularly disposable vapes containing lithium-ion batteries.

Related Topics

HEADLINE News Company

Related Read

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift

BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents

Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices

Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices